의료 분야 양자 컴퓨팅 시장 : 세계 시장 예측(2026-2032년)

The Quantum Computing in Healthcare Market is projected to grow by USD 2,311.00 million at a CAGR of 30.19% by 2032.

Quantum computing in healthcare is moving from theoretical promise toward targeted experimentation in drug discovery, genomics, medical imaging, clinical optimization, and cybersecurity. Unlike classical computing, quantum approaches use qubits, superposition, entanglement, and quantum algorithms to address complex probabilistic and combinatorial problems that are difficult to solve efficiently with conventional systems. In healthcare, these capabilities are being explored for molecular simulation, protein interaction modeling, patient stratification, radiation therapy planning, supply chain optimization, and privacy-preserving analytics. The sector remains early-stage, but momentum is supported by national quantum programs, peer-reviewed biomedical research, cloud-based quantum access, and the convergence of quantum computing with artificial intelligence, high-performance computing, and advanced health data infrastructure. For healthcare leaders, the central opportunity is not the immediate replacement of classical systems, but the development of hybrid quantum-classical workflows that can improve discovery productivity, decision support, and operational resilience as hardware, algorithms, and error mitigation techniques mature.

Transformative Shifts in the Quantum Healthcare Landscape

The healthcare quantum computing landscape is being reshaped by three structural shifts: the rise of hybrid computing architectures, the acceleration of computational life sciences, and the growing importance of secure data exchange. Hybrid quantum-classical models are increasingly relevant because today's quantum processors remain constrained by noise, limited qubit counts, and error correction challenges, while classical supercomputing and cloud infrastructure provide the stability needed for practical experimentation. In pharmaceutical research, quantum algorithms are being investigated to simulate molecular energy states and chemical interactions more efficiently, a capability with potential relevance for drug candidate screening and materials used in medical devices. In clinical care, optimization methods are being assessed for scheduling, capacity planning, imaging reconstruction, and personalized treatment planning. At the same time, post-quantum cryptography is becoming a healthcare priority as hospitals, insurers, public health agencies, and research institutions manage sensitive clinical and genomic data that must remain secure for decades. These shifts are expanding the conversation from isolated quantum experiments to broader digital health transformation strategies that include governance, workforce readiness, interoperable data, and regulatory alignment.

Cumulative Impact of Artificial Intelligence on Quantum Healthcare

Artificial intelligence is amplifying the potential value of quantum computing in healthcare by creating new demand for faster optimization, richer simulation, and more efficient feature selection across complex biomedical datasets. AI models in drug discovery, medical imaging, genomics, pathology, and clinical decision support often require large-scale data processing and advanced mathematical optimization. Quantum machine learning remains an emerging field, but research is exploring how quantum kernels, variational quantum circuits, and quantum-inspired optimization can support pattern recognition, molecular modeling, and classification tasks. The cumulative impact of AI is also practical: healthcare organizations are building data pipelines, model governance frameworks, and cloud-based analytics environments that can later support quantum-enabled workflows. However, responsible adoption requires attention to clinical validation, explainability, bias mitigation, patient privacy, and cybersecurity. Rather than viewing AI and quantum computing as separate technologies, leading healthcare ecosystems are increasingly evaluating them as complementary layers within a high-performance computing environment designed to accelerate biomedical discovery and improve operational decision-making.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is emerging as a critical region for quantum healthcare research due to strong national quantum programs, expanding biomedical innovation, and active investment in high-performance computing across China, Japan, South Korea, India, Australia, and Southeast Asia. Regional priorities include drug discovery, genomics, precision medicine, and hospital system optimization, supported by growing cloud adoption and university-led quantum research. North America benefits from deep scientific infrastructure, advanced health data ecosystems, public-sector quantum initiatives, and strong collaboration among academic medical centers, government laboratories, and technology research networks. The region is particularly active in quantum algorithms for chemistry, biomedical simulation, post-quantum cybersecurity, and AI-enabled life sciences. Latin America is at an earlier adoption stage, with opportunities tied to academic research, cloud-accessible quantum platforms, public health analytics, and cross-border scientific collaboration, particularly in Brazil and Mexico. Europe is advancing through coordinated digital, quantum, and health research programs, with emphasis on data protection, ethical AI, secure communications, and translational biomedical research. The Middle East is increasing its focus on advanced computing, digital hospitals, genomics programs, and national AI strategies, creating a foundation for quantum healthcare pilots in precision medicine and cybersecurity. Africa's near-term opportunities are linked to cloud-based access, workforce development, health system optimization, and regional research partnerships that can help apply quantum-inspired methods to public health challenges without requiring large domestic hardware infrastructure.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN's quantum healthcare opportunity is closely connected to digital health modernization, hospital network expansion, national AI strategies, and the growing use of cloud computing across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. The region's most practical near-term applications include health logistics optimization, bioinformatics collaboration, and quantum-ready workforce development. The GCC is positioning advanced computing as part of broader healthcare transformation, with digital hospitals, genomic medicine initiatives, and national cybersecurity priorities creating relevance for quantum-safe encryption and future precision medicine platforms. The European Union is one of the most structured environments for quantum healthcare development, supported by coordinated research funding, data governance frameworks, cross-border health data initiatives, and strong regulatory focus on privacy and trustworthy digital technologies. BRICS countries represent a diverse but strategically important grouping, combining major populations, expanding pharmaceutical and biotechnology capabilities, public health priorities, and increasing investment in scientific computing; China and India are especially influential due to their scale in health data, genomics, and computational research. The G7 countries remain central to quantum healthcare innovation through mature research institutions, advanced regulatory systems, and established biomedical science ecosystems. NATO-related priorities are more focused on security and resilience, making post-quantum cryptography, secure health data exchange, and protection of critical medical infrastructure important areas of relevance for healthcare systems across allied nations.

Key Country Insights Across Major Quantum Healthcare Economies

The United States is a leading environment for quantum computing in healthcare due to its extensive biomedical research base, national quantum initiatives, cloud-accessible quantum infrastructure, and strong activity in computational chemistry, genomics, medical AI, and cybersecurity. Canada contributes through quantum science clusters, university research, and strengths in health AI, while Mexico's opportunities are developing around academic partnerships, medical data modernization, and regional collaboration. Brazil is the most prominent Latin American country in this field, supported by public research universities, biotechnology activity, and interest in advanced computing for public health and life sciences. In Europe, the United Kingdom is active in quantum technologies, healthcare AI, and life sciences research; Germany combines engineering strength, pharmaceutical research, and national quantum investment; France is advancing quantum, cybersecurity, and biomedical innovation; Russia has scientific capacity in physics and mathematics with healthcare applications linked to research institutions; Italy and Spain are building capabilities through European research collaboration, digital health investment, and academic quantum programs. In Asia-Pacific, China is highly active in quantum communications, computing research, AI, genomics, and pharmaceutical innovation, making it a major force in future quantum healthcare applications. India is expanding through national quantum initiatives, digital health infrastructure, bioinformatics, and a large healthcare technology talent base. Japan brings strengths in medical technology, materials science, pharmaceuticals, and high-performance computing, while Australia supports quantum research, biotechnology, and translational health science. South Korea's capabilities in semiconductors, digital health, hospital technology, and advanced computing position it well for quantum-enabled healthcare research and future clinical optimization use cases.

Actionable Recommendations for Healthcare and Life Sciences Leaders

Industry leaders should treat quantum computing in healthcare as a strategic capability-building priority rather than a short-term procurement decision. The first recommendation is to identify problems that are computationally complex and clinically or commercially meaningful, such as molecular simulation, combinatorial optimization, radiotherapy planning, genomic analysis, and secure health data exchange. Second, organizations should build hybrid quantum-classical experimentation roadmaps using cloud-based access, simulation tools, and partnerships with universities, hospitals, and public research programs. Third, healthcare stakeholders should prepare for post-quantum cybersecurity by inventorying cryptographic assets, prioritizing systems that store long-lived patient and genomic data, and aligning migration plans with recognized standards. Fourth, data readiness is essential: quantum-enabled healthcare workflows will depend on interoperable, high-quality, ethically governed datasets. Fifth, leaders should develop cross-functional teams that include clinicians, biomedical researchers, data scientists, quantum algorithm specialists, compliance experts, and cybersecurity professionals. Finally, every pilot should be evaluated through measurable scientific, operational, and clinical criteria, with clear validation protocols before any integration into regulated healthcare decision-making.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, publicly available, and data-backed sources, including government quantum programs, public health technology strategies, peer-reviewed scientific literature, standards bodies, academic research outputs, regulatory guidance, and recognized healthcare cybersecurity resources. The methodology emphasizes triangulation across scientific, regulatory, and industry evidence to assess where quantum computing is being explored in healthcare and where practical barriers remain. Key themes were evaluated across technology maturity, use-case relevance, regional policy support, research ecosystem strength, healthcare data infrastructure, cybersecurity preparedness, and alignment with AI and high-performance computing. The analysis intentionally avoids market sizing, market share estimation, and forecasting, focusing instead on qualitative evidence, adoption drivers, technology constraints, and strategic implications. Special attention was given to distinguishing proven clinical deployment from early-stage research and experimentation, ensuring that the discussion reflects the current maturity of quantum computing in healthcare while highlighting credible pathways for future application.

Conclusion: Strategic Outlook for Quantum Computing in Healthcare

Quantum computing in healthcare is at an early but strategically significant stage, with the strongest near-term value emerging from research acceleration, optimization, quantum-inspired analytics, and post-quantum cybersecurity. The technology's healthcare impact will depend on progress in hardware reliability, error correction, algorithm development, data governance, and clinical validation. Regions and countries with strong quantum research ecosystems, mature biomedical infrastructure, and coordinated digital health strategies are best positioned to translate experimentation into practical healthcare use cases. Artificial intelligence, cloud computing, and high-performance computing are accelerating readiness by creating the data and computational foundations required for hybrid quantum-classical models. For healthcare providers, life sciences organizations, policymakers, and research institutions, the priority is to build quantum literacy, secure sensitive data against future cryptographic risks, and pursue focused pilots where quantum methods can address clearly defined scientific or operational challenges. Quantum computing will not transform healthcare through isolated breakthroughs alone; its value will come from disciplined integration into trusted, secure, and evidence-based healthcare innovation ecosystems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Quantum Computing in Healthcare Market, by Component

• 7.1. Introduction
• 7.2. Hardware
• 7.3. Services
  • 7.3.1. Managed Services
  • 7.3.2. Professional Services
• 7.4. Software
  • 7.4.1. Quantum Development Kits
  • 7.4.2. Quantum Programming Languages
  • 7.4.3. Quantum Simulation Software

8. Quantum Computing in Healthcare Market, by Technology

• 8.1. Introduction
• 8.2. Gate Based
• 8.3. Photonic Processors
• 8.4. Quantum Annealing

9. Quantum Computing in Healthcare Market, by Deployment

• 9.1. Introduction
• 9.2. On-Premise
• 9.3. Cloud-Based

10. Quantum Computing in Healthcare Market, by Application

• 10.1. Introduction
• 10.2. Clinical Trials Optimization
• 10.3. Drug Discovery
• 10.4. Genomics & Molecular Modeling
• 10.5. Medical Imaging Analysis

11. Quantum Computing in Healthcare Market, by End User

• 11.1. Introduction
• 11.2. Contract Research Organizations
• 11.3. Hospitals & Diagnostic Centers
• 11.4. Pharmaceutical & Biotechnology Companies
• 11.5. Research Institutes

12. Quantum Computing in Healthcare Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Quantum Computing in Healthcare Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Quantum Computing in Healthcare Market, by Country

• 14.1. United States
• 14.2. China
• 14.3. Germany
• 14.4. United Kingdom
• 14.5. India
• 14.6. Japan
• 14.7. Russia
• 14.8. Brazil
• 14.9. Canada
• 14.10. Italy
• 14.11. Mexico
• 14.12. France
• 14.13. Spain
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Accenture PLC
• 16.2. Amazon Web Services, Inc.
• 16.3. Atos SE
• 16.4. Classiq Technologies Ltd.
• 16.5. D-Wave Quantum Inc.
• 16.6. Fujitsu Limited
• 16.7. Google LLC by Alphabet Inc.
• 16.8. Honeywell International Inc.
• 16.9. ID Quantique
• 16.10. International Business Machines Corporation
• 16.11. IonQ, Inc.
• 16.12. Microsoft Corporation
• 16.13. NVIDIA Corporation
• 16.14. PASQAL SAS
• 16.15. Protiviti India Member Private Limited
• 16.16. QC Ware
• 16.17. Quantinuum Ltd.
• 16.18. Quantum Xchange
• 16.19. Rigetti & Co, LLC
• 16.20. SandboxAQ
• 16.21. Xanadu Quantum Technologies Inc.